Lidia Luzon-Franco
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy.
Journal: Experimental hematology & oncology
Published: January 14, 2026
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.
Journal: NAR cancer
Published: October 17, 2024
Peripheral blood tumor-infiltrating lymphocytes in a neuroblastoma model.
Journal: Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica
Published: April 07, 2020
Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient.
Journal: Cancers
Published: April 02, 2020
Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.
Journal: Exercise immunology review
Published: March 07, 2020
Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma.
Journal: Oncotarget
Published: July 16, 2019
Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.
Journal: Cancer letters
Published: October 07, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026